Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Xenotransplantation-current status and future perspectives.

Emanuele Cozzi1, Erika Bosio, Michela Seveso

  • 1Department of Medical and Surgical Sciences, University of Padua, Clinica Chirurgica III, Via Giustiniani, 2, 35128 Padova, Italy. emanuele.cozzi@unipd.it

British Medical Bulletin
|May 26, 2006
PubMed
Summary

Genetically engineered pig organs show promise for primate transplants, overcoming initial rejection. Further research is needed to address humoral immune responses and coagulation issues for long-term xenograft survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

The Sex of Donor and Recipients in Solid Organ Transplantation: An in Depth Analysis Across the Council of Europe Member States.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Breaking Barriers: Proof of Concept for Selective Coronary Endothelial Decellularization in Whole Porcine Hearts for Xenotransplantation.

Xenotransplantation·2026
Same author

Pathologic evaluation of pig kidney and heart xenografts: 2024 recommendations from the Banff Xenotransplantation Pathology Working Group.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Autoantibody Profiling in Cardiomyopathies: Toward Immune-Guided Risk Stratification and Therapy.

Journal of clinical medicine·2026
Same author

From transplant rejection to coronary no-reflow: an immune-ischemic framework for antibody-mediated microvascular dysfunction.

American journal of physiology. Heart and circulatory physiology·2026

Area of Science:

  • Transplantation immunology
  • Xenotransplantation research
  • Genetically engineered animal models

Background:

  • Immunological barriers hinder long-term survival of pig organs in primates.
  • Genetically engineered animals have overcome hyperacute rejection.
  • Acute humoral xenograft rejection (AHXR) remains a significant obstacle.

Purpose of the Study:

  • Identify targets for immune intervention in xenotransplantation.
  • Overcome the remaining immunological obstacles to xenograft survival.
  • Improve long-term outcomes for pig-to-primate organ transplantation.

Main Methods:

  • Genetic engineering of donor animals.
  • Investigating immune responses in xenograft recipients.
  • Developing strategies to control humoral immune responses and coagulation disorders.

Related Experiment Videos

Main Results:

  • Genetically engineered pigs have overcome hyperacute rejection barriers.
  • Porcine xenografts can support non-human primate life for months.
  • AHXR is the primary immunological hurdle currently addressed.

Conclusions:

  • Controlling anti-pig humoral immunity and preventing coagulation disorders are key to overcoming AHXR.
  • Ongoing research in accommodation, tolerance, immune suppression, and genetic engineering is crucial.
  • Clinical progression requires more robust efficacy data and a favorable risk/benefit ratio in animal models.